Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 42
MetricValuePeriodScopeSource row
Revenue¥252m2025-01-01 → 2025-06-30StandaloneNet sales
Revenue¥781m2024-01-01 → 2024-12-31StandaloneNet sales (5-year summary)
Revenue¥264m2024-01-01 → 2024-06-30StandaloneNet sales
Operating income−¥537m2025-01-01 → 2025-06-30StandaloneOperating income
Operating income−¥581m2024-01-01 → 2024-06-30StandaloneOperating income
Ordinary income−¥539m2025-01-01 → 2025-06-30StandaloneOrdinary income
Ordinary income−¥1.0bn2024-01-01 → 2024-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥563m2024-01-01 → 2024-06-30StandaloneOrdinary income
Profit before tax−¥539m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Profit before tax−¥562m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Net income−¥540m2025-01-01 → 2025-06-30StandaloneProfit loss
Net income−¥1.0bn2024-01-01 → 2024-12-31StandaloneNet income loss (5-year summary)
Net income−¥564m2024-01-01 → 2024-06-30StandaloneProfit loss
Total assets¥2.0bnat 2025-06-30StandaloneAssets
Total assets¥2.5bnat 2024-12-31StandaloneAssets
Total assets¥1.6bnat 2024-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥443mat 2025-06-30StandaloneLiabilities
Total liabilities¥549mat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2025-06-30StandaloneNet assets
Net assets / equity¥1.9bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2024-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2025-06-30StandaloneCash and deposits
Cash and deposits¥2.1bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥673m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥677m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Financing cash flow¥85m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.7bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥455m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-7.972025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.542024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.212024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio76.9%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.4%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio68.0%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued68,053,800at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued66,969,000at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued56,387,000at 2024-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥280m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2025-01-01 → 2025-06-30−¥396m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2025-01-01 → 2025-06-30¥252m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2025-01-01 → 2025-06-30¥252m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2025-01-01 → 2025-06-30¥139m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30−¥257m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥269m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥447m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2024-01-01 → 2024-06-30¥135m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30−¥312m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 427
ItemContextValueUnit
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember1521000JPY
Other noePrior1YTDDuration_NonConsolidatedMember0JPY
Other noeCurrentYTDDuration_NonConsolidatedMember-JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember3286000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember3462000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-563345000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-539020000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration_NonConsolidatedMember1302000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration_NonConsolidatedMember350000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember1302000JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember350000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-562043000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-538670000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1915000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1620000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1915000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1620000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-563958000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-540290000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-562043000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-538670000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember586000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember-JPY
Subsidy income ope cfPrior1YTDDuration_NonConsolidatedMember-19738000JPY
Subsidy income ope cfCurrentYTDDuration_NonConsolidatedMember-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember32500000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember11689000JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember11664000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember-495000JPY
Decrease increase in prepaid expenses ope cfPrior1YTDDuration_NonConsolidatedMember-40692000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration_NonConsolidatedMember-30787000JPY
Decrease increase in advance payments ope cfPrior1YTDDuration_NonConsolidatedMember-20111000JPY
Decrease increase in advance payments ope cfCurrentYTDDuration_NonConsolidatedMember-2249000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration_NonConsolidatedMember7749000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration_NonConsolidatedMember8335000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember-14720000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember9632000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration_NonConsolidatedMember-53467000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember-75231000JPY
Increase decrease in accrued expenses ope cfPrior1YTDDuration_NonConsolidatedMember-1218000JPY
Increase decrease in accrued expenses ope cfCurrentYTDDuration_NonConsolidatedMember-18124000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember-11621000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember-33403000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-671113000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-669305000JPY
Interest income received ope cfPrior1YTDDuration_NonConsolidatedMember17000JPY
Interest income received ope cfCurrentYTDDuration_NonConsolidatedMember771000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-1282000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-1940000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-5010000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass